4 European Projects Found
Searched on 125080 European Projects
FINISHED
European network for innovative microbioreactor applications in bioprocess development (EUROMBR)
Start date: Nov 1, 2013, End date: Oct 31, 2017,
"The objective is to deliver a trans-European network of industrially oriented specialists fully trained in the development and application of microbioreactor (MBR) technology to support development of innovative bio-based manufacturing processes. The specialistis will be trained by leaders in the field and with state of the art equipment and methodologies. MBRs are a promising tool for screening ...
Read Project
13
Partners Participants
FINISHED
Sample In - Answer Out Optochemical Sensing Systems (SAMOSS)
Start date: Oct 1, 2013, End date: Sep 30, 2017,
Biosensor development is a very promising and prospective field of research in food- clinical- and environmental analysis. Besides conventional analytical methods biosensors specifically detect only some decisive components. However, miniaturised sensor systems are able to detect components in the femto/ato-gramm region with almost no interference to other components in the investigated system. Th ...
Read Project
8
Partners Participants
FINISHED
Label Free Particle Sorting (LAPASO)
Start date: Oct 1, 2013, End date: Sep 30, 2017,
"LAPASO will provide a unique training opportunity for 15 fellows in a highly interdisciplinary and intersectorial environment with the overarching scientific objective of advancing diagnostics in a wide range of critical medical conditions using advanced microfluidics and nanobiotechnology integration.Microfluidic particle fractionation based on the inherent properties of e.g. cells, microorganis ...
Read Project
8
Partners Participants
FINISHED
A Nanoscale Artificial Nose to easily detect Volatile Biomarkers at Early stages of Lung Cancer and Related Genetic Mutations (LCAOS)
Start date: Apr 1, 2011, End date: Mar 31, 2015,
The LCAOS project will develop and test a new diagnostic tool, able to detect:(i) the presence of lung cancer (LC), and(ii) an increased risk of a patient developing LC in the future.Diagnostic tests currently available are unsuitable for widespread screening because they are costly, occasionally miss tumours, are not time-efficient, nor free of complications.LCAOS will overcome these problems by ...
Read Project
